BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27793648)

  • 1. Shikonin regulates C-MYC and GLUT1 expression through the MST1-YAP1-TEAD1 axis.
    Vališ K; Talacko P; Grobárová V; Černý J; Novák P
    Exp Cell Res; 2016 Dec; 349(2):273-281. PubMed ID: 27793648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the hippo signaling pathway in human gastric cancer.
    Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
    Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis.
    Lin C; Xu X
    Biomed Pharmacother; 2017 Nov; 95():789-794. PubMed ID: 28892790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
    Ota M; Sasaki H
    Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α.
    Mammoto A; Muyleart M; Kadlec A; Gutterman D; Mammoto T
    Microvasc Res; 2018 Sep; 119():73-83. PubMed ID: 29680477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
    Chai J; Xu S; Guo F
    Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility.
    Al-Mathkour MM; Dwead AM; Alp E; Boston AM; Cinar B
    Sci Rep; 2022 Mar; 12(1):3840. PubMed ID: 35264657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.
    Subramaniam D; Ponnurangam S; Ramalingam S; Kwatra D; Dandawate P; Weir SJ; Umar S; Jensen RA; Anant S
    Cells; 2021 Jun; 10(7):. PubMed ID: 34206989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
    J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
    Li H; Fu L; Liu B; Lin X; Dong Q; Wang E
    Gene; 2019 Apr; 693():16-24. PubMed ID: 30690182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
    Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
    J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival.
    Yuan H; Liu H; Liu Z; Zhu D; Amos CI; Fang S; Lee JE; Wei Q
    Int J Cancer; 2015 Aug; 137(3):638-45. PubMed ID: 25628125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hippo Signaling Pathway Regulates Ovarian Function via the Proliferation of Ovarian Germline Stem Cells.
    Ye H; Li X; Zheng T; Hu C; Pan Z; Huang J; Li J; Li W; Zheng Y
    Cell Physiol Biochem; 2017; 41(3):1051-1062. PubMed ID: 28245464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
    Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
    PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.
    Zhao Q; Assimopoulou AN; Klauck SM; Damianakos H; Chinou I; Kretschmer N; Rios JL; Papageorgiou VP; Bauer R; Efferth T
    Oncotarget; 2015 Nov; 6(36):38934-51. PubMed ID: 26472107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.
    Baia GS; Caballero OL; Orr BA; Lal A; Ho JS; Cowdrey C; Tihan T; Mawrin C; Riggins GJ
    Mol Cancer Res; 2012 Jul; 10(7):904-13. PubMed ID: 22618028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo pathway functions as a downstream effector of AKT signaling to regulate the activation of primordial follicles in mice.
    Hu LL; Su T; Luo RC; Zheng YH; Huang J; Zhong ZS; Nie J; Zheng LP
    J Cell Physiol; 2019 Feb; 234(2):1578-1587. PubMed ID: 30078193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway.
    Chao Y; Wang Y; Liu X; Ma P; Shi Y; Gao J; Shi Q; Hu J; Yu R; Zhou X
    J Neurooncol; 2015 Jan; 121(2):279-88. PubMed ID: 25373346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Yap1/Taz signaling in ischemic heart disease and dilated cardiomyopathy.
    Hou N; Wen Y; Yuan X; Xu H; Wang X; Li F; Ye B
    Exp Mol Pathol; 2017 Dec; 103(3):267-275. PubMed ID: 29154888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
    Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
    Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.